Liposomal boron delivery for neutron capture therapy

Area of Science:

• Oncology
• Nuclear Medicine
• Biotechnology

Background:

• Boron neutron capture therapy (BNCT) relies on the nuclear reaction between boron-10 and thermal neutrons for tumor cell destruction.
• High accumulation and selective delivery of boron compounds into tumor tissues are critical for effective BNCT and minimizing damage to healthy cells.

Purpose of the Study:

• To summarize laboratory approaches using boron lipid liposomes for enhanced boron delivery in BNCT.
• To review recent developments in liposomal drug delivery systems for BNCT applications.

Main Methods:

• Investigating liposomal drug delivery systems (DDS) for targeted and controlled release of boron-10 compounds.
• Developing and utilizing boron ion cluster lipids for incorporation into liposomal bilayers.

Main Results:

• Liposomal DDS offer a promising strategy for improving boron compound delivery in BNCT.
• Boron lipid liposome approaches facilitate targeted accumulation of boron in tumor tissues.

Conclusions:

• Liposomal drug delivery systems, particularly those utilizing boron lipid liposomes, represent an advanced approach for enhancing BNCT efficacy.
• Further development in liposomal boron delivery systems is crucial for optimizing cancer treatment outcomes with BNCT.